Evidence map›Paper›PMID 26556961›Full record

ArticleJournal of the Royal Statistical Society. Series A, (Statistics in Society)2015

A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening.

Hormuzd A Katki, Li C Cheung, Barbara Fetterman, Philip E Castle, Rajeshwari Sundaram

Abstract read
In one paragraph

Article in Journal of the Royal Statistical Society. Series A, (Statistics in Society), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. A Comparison of Methods for Modeling Multistate Cancer Progression Using Screening Data with Censoring after Intervention.Medical decision making : an international journal of the Society for Medical Decision Making · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hormuzd A KatkiDivision of Cancer Epidemilogy and Genetics, US National Cancer Institute, NIH, Bethesda MD, USA.
Li C CheungInfomation Management Services, Inc., Calverton MD, USA.
Barbara FettermanKaiser Permanente Northern California, Berkeley CA, USA.
Philip E CastleAlbert Einstein College of Medicine, The Bronx NY, USA.
Rajeshwari SundaramDivision of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville MD, USA.

Funding

Methods for Epidemiology StudiesZIACP010181 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBERT, PAUL · 2009 to 2025
$34.8M
Risk prediction methodsZIACP010188 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBERT, PAUL · 2010 to 2025
$8.9M
Statistical Modeling of Human FecundityZIAHD008883 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI SUNDARAM, RAJESHWARI · 2009 to 2025
$3.6M
The analysis of survival dataZIAHD008856 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI SUNDARAM, RAJESHWARI · 2009 to 2025
$1.2M
Intramural NIH HHS ZIA CP010188
6 · The paper itself

Abstract

New cervical cancer screening guidelines in the US and many European countries recommend that women get tested for human papillomavirus (HPV). To inform decisions about screening intervals, we calculate the increase in precancer/cancer risk per year of continued HPV infection. However, both time to onset of precancer/cancer and time to HPV clearance are interval-censored, and onset of precancer/cancer strongly informatively censors HPV clearance. We analyze this bivariate informatively interval-censored data by developing a novel joint model for time to clearance of HPV and time to precancer/cancer using shared random-effects, where the estimated mean duration of each woman's HPV infection is a covariate in the submodel for time to precancer/cancer. The model was fit to data on 9,553 HPV-positive/Pap-negative women undergoing cervical cancer screening at Kaiser Permanente Northern California, data that were pivotal to the development of US screening guidelines. We compare the implications for screening intervals of this joint model to those from population-average marginal models of precancer/cancer risk. In particular, after 2 years the marginal population-average precancer/cancer risk was 5%, suggesting a 2-year interval to control

Indexed as

cancer screeningHPVjoint modeling of longitudinalmedical guidelinesrisk modelingsurvival data

Identifiers

PMID26556961
PMCPMC4635446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.